Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AsedaSciences does not develop its own therapeutics but provides an advanced AI-enabled SaaS platform to predict human and environmental toxicity risks of compounds at the earliest stages of R&D. The company’s proprietary high-content cellular screens combined with machine learning allow rapid identification of potentially toxic compounds before animal testing or clinical trials. Their technology supports reduced late-stage attrition in drug pipelines by flagging unsafe candidates earlier. No direct clinical results are reported as they do not run clinical programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AsedaSciences.